What is PharmaLink?
Founded in 2000, PharmaLink, Inc. operates as a premier provider of pharmaceutical reverse logistics and disposal services. By managing the complex lifecycle of pharmaceutical products, the company offers a comprehensive 360-degree view of supply chain requirements. Their service model is designed to optimize cycle times while ensuring the secure and compliant removal of unwanted inventory from the marketplace. This operational focus provides essential infrastructure for healthcare businesses, effectively bridging the gap between distribution and final disposal in a highly regulated industry.
How much funding has PharmaLink raised?
PharmaLink has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in PharmaLink
PPP
Public-Private Partnership
What's next for PharmaLink?
With this major enterprise-level funding, PharmaLink is poised to accelerate its strategic initiatives aimed at enhancing supply chain resilience. The capital will likely be deployed to scale logistics infrastructure and refine disposal technologies, ensuring the firm remains at the forefront of regulatory compliance and operational efficiency. As the healthcare sector continues to demand more sophisticated reverse logistics solutions, PharmaLink's ability to integrate these services into existing supply chains will be a key driver of its future growth and market penetration.
See full PharmaLink company page
